http://www.acc.org/Feed?clinicalTopicID=729dd08e-0a1b-4aa5-bd2a-5e3f31006cb0 Clinical Topic Feed: Acute Heart Failure en /Latest-in-Cardiology/Articles/2026/04/21/15/23/accel-lite-21apr2026 In this interview, Richard A. Chazal MD, MACC and Vishal N. Rao, MD, MPH examine the interconnectedness of cardiovascular (CV) and hepatic risk. 1776785160000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/04/16/17/02/Higher-CV-Risk Patients and survivors of hematological malignancies face substantially elevated short- and long-term risk of cardiovascular disease compared with the general population – with risk varying significantly by malignancy subtype, according to a population-based cohort study published April 8 in JACC. 1776442380000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/04/15/17/20/Real-World-TTVR In the first year of its approval in the U.S., transcatheter tricuspid valve replacement (TTVR) in patients with severe tricuspid regurgitation (TR) was found to be safe and effective by STS/ACC TVT Registry data, showing 30-day outcomes consistent with the TRISCEND II pivotal trial... 1776278460000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/15/13/28/eagles-eye-view-15apr2026 In this week’s View, Dr. Eagle explores four recent articles that examine how we care for patients. First, Dr. Eagle looks at a new state-of-the-art review that outlines a multidisciplinary framework for cardiogenic shock survivorship. 1776259800000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/04/08/14/08/State-of-the-Art-Review-Cardiogenic-Shock With survival rates after cardiogenic shock (CS) increasing, a JACC State-of-the-Art Review outlines a multidisciplinary, longitudinal approach to CS care aimed at "providing a clinically actionable structure for care pathways, resource planning and future research." 1775658600000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/07/14/54/accel-lite-07apr2026 Pulmonary arterial hypertension (PAH) remains a devastating, progressive disease with high morbidity and mortality despite advances in targeted therapies. 1775573940000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1775045400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/01/01/Pulse-of-ACC Quick-read articles of particular interest to ACC members. 1775045340000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-trifr-acc-2026 Transcatheter tricuspid edge-to-edge repair (T-TEER) in addition to standard-of-care medical therapy reduced the risk of death, myocardial infarction (MI), stroke and hospitalization for heart failure (HF) compared with standard-of-care alone in patients with severe symptomatic tricuspid regurgitation (TR)... 1774818180000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-1045am-cadence-acc-2026 Sotatercept, an activin signaling inhibitor, was associated with significant improvements in blood pressure and vascular health in patients with heart failure with preserved ejection fraction (HFpEF) and severe combined post and precapillary pulmonary hypertension (CpcPH), according to results of the CADENCE study presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in Circulation. 1774800360000 Articles and Stories